Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Income Statement [Abstract]        
Sales $ 413,295 $ 339,056 $ 1,031,832 $ 730,955
Cost of sales (553,917) (404,520) (1,038,600) (739,247)
Gross loss (140,622) (65,464) (6,768) (8,292)
Operating Expenses        
Selling and marketing 56,710 36,674 207,750 82,878
General and administrative 1,634,532 1,718,322 3,417,417 3,378,354
Depreciation and amortization 43,357 6,086 64,972 52,073
Total operating expenses 1,734,599 1,761,082 3,690,139 3,513,305
Loss from Operations (1,875,221) (1,826,546) (3,696,907) (3,521,597)
Other Expenses        
Interest expense, net (53,477) (63,681) (135,333) (90,933)
Gain on sale of investment in subsidiary 199,200
Common stock price modification (941,530) (941,530)
Warrant modification expenses (68,548) (68,548)
Total other expenses (53,477) (1,073,759) 63,867 (1,101,011)
Loss from Continuing Operations (1,928,698) (2,900,305) (3,633,040) (4,622,608)
Loss from Discontinued Operations (394,364) (106,543) (668,326)
Net Loss (1,928,698) (3,294,669) (3,739,583) (5,290,934)
Deemed dividend to Series B preferred stockholders (48,283) (51,336)
Net loss attributable to common stockholders $ (1,976,981) $ (3,294,669) $ (3,790,919) $ (5,290,934)
Net loss per basic and diluted common share:        
Loss from continuing operations $ (0.04) $ (0.07) $ (0.08) $ (0.12)
Loss from discontinued operations (0.01) (0.01)
Net loss per common share $ (0.04) $ (0.08) $ (0.08) $ (0.13)
Weighted Average Number of Common Shares Outstanding        
Basic and Diluted 42,974,812 41,055,670 42,954,832 40,096,907